Caseware UK (AP4) 2023.0.135 2023.0.135 2022-01-01falseNo description of principal activity22truetruefalse 11883133 2022-01-01 2022-12-31 11883133 2021-01-01 2021-12-31 11883133 2022-12-31 11883133 2021-12-31 11883133 2021-01-01 11883133 c:PriorPeriodIncreaseDecrease 2022-01-01 2022-12-31 11883133 1 2022-01-01 2022-12-31 11883133 d:Director1 2022-01-01 2022-12-31 11883133 c:Buildings c:LongLeaseholdAssets 2022-01-01 2022-12-31 11883133 c:Buildings c:LongLeaseholdAssets 2022-12-31 11883133 c:Buildings c:LongLeaseholdAssets 2021-12-31 11883133 c:CurrentFinancialInstruments 2022-12-31 11883133 c:CurrentFinancialInstruments 2021-12-31 11883133 c:CurrentFinancialInstruments c:WithinOneYear 2022-12-31 11883133 c:CurrentFinancialInstruments c:WithinOneYear 2021-12-31 11883133 c:ShareCapital 2022-12-31 11883133 c:ShareCapital 2021-12-31 11883133 c:ShareCapital 2021-01-01 11883133 c:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 11883133 c:RetainedEarningsAccumulatedLosses 2022-12-31 11883133 c:RetainedEarningsAccumulatedLosses c:PriorPeriodIncreaseDecrease 2022-01-01 2022-12-31 11883133 c:RetainedEarningsAccumulatedLosses 2021-01-01 2021-12-31 11883133 c:RetainedEarningsAccumulatedLosses 2021-12-31 11883133 c:RetainedEarningsAccumulatedLosses 2021-01-01 11883133 d:OrdinaryShareClass1 2022-01-01 2022-12-31 11883133 d:OrdinaryShareClass1 2022-12-31 11883133 d:OrdinaryShareClass1 2021-12-31 11883133 d:FRS102 2022-01-01 2022-12-31 11883133 d:Audited 2022-01-01 2022-12-31 11883133 d:FullAccounts 2022-01-01 2022-12-31 11883133 d:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 11883133 d:SmallCompaniesRegimeForAccounts 2022-01-01 2022-12-31 11883133 e:PoundSterling 2022-01-01 2022-12-31 11883133 c:ShareCapital c:PriorPeriodErrorIncreaseDecrease 2022-01-01 2022-12-31 11883133 c:RetainedEarningsAccumulatedLosses c:PreviouslyStatedAmount 2021-12-31 11883133 c:PreviouslyStatedAmount 2021-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 11883133










Passport Health Ltd










Financial statements

Information for filing with the registrar

For the year ended 31 December 2022

 
Passport Health Ltd
Registered number: 11883133

Balance sheet
As at 31 December 2022

As restated
2022
2021
Note
£
£

Fixed assets
  

Tangible assets
 5 
8,122
9,311

  
8,122
9,311

Current assets
  

Stocks
  
4,640
3,212

Debtors: amounts falling due within one year
 6 
-
2,763

Cash at bank and in hand
  
44,893
21,257

  
49,533
27,232

Creditors: amounts falling due within one year
 7 
(271,786)
(106,413)

Net current liabilities
  
 
 
(222,253)
 
 
(79,181)

  

Net liabilities
  
(214,131)
(69,870)


Capital and reserves
  

Called up share capital 
 8 
297,704
297,704

Profit and loss account
  
(511,835)
(367,574)

  
(214,131)
(69,870)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




P C Fishburn
Director
Date: 2 April 2024

The notes on pages 3 to 7 form part of these financial statements.
Page 1

 
Passport Health Ltd
 

Statement of changes in equity
For the year ended 31 December 2022


Called up share capital
Profit and loss account
Total equity

£
£
£


At 1 January 2021
297,704
(237,090)
60,614


Comprehensive income for the year

Loss for the year (as restated)
-
(130,484)
(130,484)



At 1 January 2022 (as previously stated)
297,704
(372,740)
(75,036)

Prior year adjustment (note 9)
-
5,166
5,166


At 1 January 2022 (as restated)
297,704
(367,574)
(69,870)


Comprehensive income for the year

Loss for the year
-
(144,261)
(144,261)


At 31 December 2022
297,704
(511,835)
(214,131)


The notes on pages 3 to 7 form part of these financial statements.
Page 2

 
Passport Health Ltd
 

 
Notes to the financial statements
For the year ended 31 December 2022

1.


General information

Passport Health Ltd is a private company limited by shares incorporated in England. The registered address is 207 Regent Street, 3rd Floor. London, England, W1B 3HH. The company's principal activity is the provision of a full range of medications and immunizations.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The accounts have been prepared on a going concern basis despite the company reporting a loss of £144,261 (2021: £130,484). The company has net liability of £214,131 (2021: £69,870) at the year end.
The company relies upon the continued support from its parent company, Passport Health International LLC, who have confirmed provision of such support. The group confirmed their cash and marketable securities will satisfy the projected working capital and capital expenditure requirements for the group for at least the next 12 months. Liquidity and capital expenditure requirements are continuously reviewed by the group.
On this basis, the Director has concluded the company has adequate resources to continue in operational existence for the foreseeable future.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Page 3

 
Passport Health Ltd
 

 
Notes to the financial statements
For the year ended 31 December 2022

2.Accounting policies (continued)

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold property
-
10%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. 
At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
Passport Health Ltd
 

 
Notes to the financial statements
For the year ended 31 December 2022

2.Accounting policies (continued)

 
2.9

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is British Pound Sterling.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.10

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.11

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.


3.


Judgments in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires the directors to make judgments, estimates and assumptions that can affect the amounts reported for assets and liabilities, and the results for the year. The nature of estimation is such though that actual outcomes could differ significantly from those estimates. 
The following judgments have had the most significant impact on the amounts recognised in the financial statements. 
Depreciation of fixed assets
The annual depreciation charge for tangible assets is senstive to changes in the estimated useful lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. See note 5 for the carrying amount of the fixed assets and note 2.4 for the useful economic lives.

Page 5

 
Passport Health Ltd
 

 
Notes to the financial statements
For the year ended 31 December 2022

4.


Employees

The average monthly number of employees, including directors, during the year was 2 (2021 - 2).


5.


Tangible fixed assets





Leasehold property

£



Cost 


At 1 January and 31 December 2022

11,886



Depreciation


At 1 January 2022
2,575


Charge for the year
1,189



At 31 December 2022

3,764



Net book value



At 31 December 2022
8,122



At 31 December 2021
9,311


6.


Debtors

As restated
2022
2021
£
£


Other debtors
-
1,728

Prepayments and accrued income
-
1,035

-
2,763



7.


Creditors: Amounts falling due within one year

As restated
2022
2021
£
£

Trade creditors
6,469
2,859

Amounts owed to group undertakings
237,377
86,359

Other taxation and social security
2,380
-

Accruals and deferred income
25,560
17,195

271,786
106,413


Page 6

 
Passport Health Ltd
 

 
Notes to the financial statements
For the year ended 31 December 2022

8.


Share capital

2022
2021
£
£
Allotted, called up and fully paid



297,704 (2021 - 297,704) Ordinary shares of £1.00 each
297,704
297,704



9.


Prior year adjustment

During the year ended 31 December 2022, it was identified that the liability with HM Revenue & Customs was incorrectly calculated in the year ended 31 December 2021. This led to an overstatement of expenses of £5,166 and amending the HM Revenue & Customs balance from a creditor of £3,603 to a debtor of £1,563. 
A prior year adjustment has been included and the comparative figures for the year ended 31 December 2021 have been restated accordingly. The effect of the restatement is to increase loss after tax by £5,166 and increase equity by £5,166 for the year ended 31 December 2021.


10.


Related party transactions

The company has taken advantage of the exemption provided by paragraph 1AC.35 of Financial Reporting Standard 102 from disclosing related party transactions entered into between the Company and other Group Companies, where the subsidiary undertaking is wholly owned by a member of the Group. 


11.


Post balance sheet events

On 23 February 2024, the company signed an additional premises licence agreement. This agreement has a six month commitment, starting 1 March 2024. The total commitment is £10,800. 


12.


Controlling party

The ultimate parent company and controlling party is Outlier Holdings LLC, a company incorporated in the United States of America. 
Passport Health Limited is included in the group accounts prepared by Passport Health Holdings LLC, a company incorporated in the United States of America. These accounts can be obtained on request from 4343 E Outlier Blvd, Phoenix, AZ 85008, United States of America. 


13.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2022 was qualified.

The qualification in the audit report was as follows:
We did not observe the counting of physical stock at the end of the year and have been unable to satisfy
ourselves with alternative means concerning the stock quantities held as at 31 December 2022, which is stated in the balance sheet as £4,640. As a result of this matter, we are unable to determine whether any adjustments might have been found necessary in respect of recorded or unrecorded stock. 

The audit report was signed on 2 April 2024 by Stephen Moss BSc (Hons) ACA (Senior statutory auditor) on behalf of Kreston Reeves LLP.

Page 7

 
Passport Health Ltd
 

Page 8